PACLITAXEL-ALBUMINE Spirig HC subst sèche 100 mg
7680691530012
CH-69153
L01CD01
07.16.1.
Reimbursement limitations:
PaclitaAlbSp
Adénocarcinome du pancréas
En association avec la gemcitabine, dans le traitement de première ligne de …
1 / 3
google
Details
- Product number
- 6915301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- paclitaxelum 100 mg ut complexus paclitaxeli et albumini humani, albuminum humanum, natrii caprylas corresp. natrium max. 0.28 mg, pro vitro.
Articles (1)
Paclitaxel-Albumin Spirig HC 5 mg/ml, Pulver zur Herstellung einer Infusionsdispersion
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 210.20
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69153
- Drug name
- Paclitaxel-Albumin Spirig HC, Pulver zur Herstellung einer Infusionsdispersion
- Galenic form
- PULVID
- ATC Code
- L01CD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/08/2024
- Authorization expiration date
- 26/08/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PACLITAXEL-ALBUMINE Spirig HC subst sèche 100 mg
- Description (DE)
- PACLITAXEL-ALBUMIN Spirig HC Trockensub 100 mg
- Market launch
- 27/08/2024
- Narcotic (BTM)
- No